NCT06707233View on ClinicalTrials.gov

Y-90 SIRT for Unresectable HCC Larger Than 7cm

PHASE2RecruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2027

Conditions
Hepatocellular Carcinoma Non-Resectable
Interventions
PROCEDURE

SIRT

The patients will receive 1-2 sessions of SIRT.

Trial Locations (2)

510260

NOT_YET_RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER